Cargando…

Computed tomography-guided permanent brachytherapy for locoregional recurrent gastric cancer

BACKGROUND: Locoregional recurrence is the typical pattern of recurrence in gastric cancer, and cannot be removed by surgery in most of the patients. We aimed to evaluate the feasibility and efficacy of computed tomography (CT)-guided brachytherapy for patients with locoregional recurrent gastric ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Liangrong, Wu, Changping, Wu, Jun, Zhou, Wenjie, Ji, Mei, Zhang, Hongyu, Zhao, Jiemin, Huang, Yuanquan, Pei, Honglei, Li, Zhong, Ju, Jingfang, Jiang, Jingting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485112/ https://www.ncbi.nlm.nih.gov/pubmed/22827960 http://dx.doi.org/10.1186/1748-717X-7-114

Ejemplares similares

An analysis of brachytherapy with computed tomography-guided permanent implantation of Iodine-125 seeds for recurrent nonkeratin nasopharyngeal carcinoma
por: Shen, Xinying, et al.
Publicado: (2015)

Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer
por: Shi, Liangrong, et al.
Publicado: (2012)

A rare case of eight multiple primary malignant neoplasms in a female patient: A case report and review of the literature
por: ZHAO, JIEMIN, et al.
Publicado: (2015)

Synergistic antitumor effects of combined deguelin and cisplatin treatment in gastric cancer cells
por: LI, ZHENGGUANG, et al.
Publicado: (2014)

The combination of systemic chemotherapy and local treatment may improve the survival of patients with unresectable metastatic colorectal cancer
por: Zhao, Jiemin, et al.
Publicado: (2017)

The phylogeny of permanent prostate brachytherapy
por: Aronowitz, Jesse N., et al.
Publicado: (2013)

Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients
por: Chen, Lujun, et al.
Publicado: (2016)

Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions
por: Liu, Juan, et al.
Publicado: (2020)

Iodine-125 Brachytherapy Prophylaxis after Radiofrequency Ablation Cannot Benefit Patients in High Risk of Locoregional Hepatocellular Carcinoma Recurrence
por: Tu, Jian-Fei, et al.
Publicado: (2017)

Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

Prognostic value of tumor infiltrating NK cells and macrophages in stage II+III esophageal cancer patients
por: Xu, Bin, et al.
Publicado: (2016)

Prognostic Significance of miR-181b and miR-21 in Gastric Cancer Patients Treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin
por: Jiang, Jingting, et al.
Publicado: (2011)

Impact of target area selection in (125) Iodine seed brachytherapy on locoregional recurrence in patients with non‐small cell lung cancer
por: Yan, Wei‐Liang, et al.
Publicado: (2017)

Surgical resection of late solitary locoregional gastric cancer recurrence in stomach bed
por: Watanabe, Masanori, et al.
Publicado: (2012)

Focal partial salvage low-dose-rate brachytherapy for local recurrent prostate cancer after permanent prostate brachytherapy with a review of the literature
por: Kunogi, Hiroaki, et al.
Publicado: (2016)

Multiple nodal locoregional recurrence of pheochromocytoma
por: Ramírez-Plaza, César Pablo, et al.
Publicado: (2015)

Reirradiation for Locoregional Recurrent Breast Cancer
por: Fattahi, Sayeh, et al.
Publicado: (2020)

Comprehensive prognostic modeling of locoregional recurrence after radiotherapy for patients with locoregionally advanced hypopharyngeal squamous cell carcinoma
por: Liu, Hongjia, et al.
Publicado: (2023)

CT-guided (125)I brachytherapy for recurrent ovarian cancer
por: Liu, Ping, et al.
Publicado: (2017)

Reduction of gastric cancer proliferation and invasion by miR-15a mediated suppression of Bmi-1 translation
por: Wu, Changping, et al.
Publicado: (2016)

Prognostic values of tissue factor and its alternatively splice transcripts in human gastric cancer tissues
por: Wu, Min, et al.
Publicado: (2017)

Paclitaxel/oxaliplatin/fluorouracil (TOF) regimen versus S-1/oxaliplatin (SOX) regimen for metastatic gastric cancer patients
por: Dai, Xichao, et al.
Publicado: (2016)

Computed tomography-guided implantation of (125)I seeds brachytherapy for recurrent multiple pulmonary oligometastases: initial experience and results
por: Li, Jie, et al.
Publicado: (2017)

Permanent Interstitial Brachytherapy for Previously Irradiated Head and Neck Cancer
por: Breen, William, et al.
Publicado: (2018)

MiR-629 promotes human pancreatic cancer progression by targeting FOXO3
por: Yan, Haijiao, et al.
Publicado: (2017)

Lymph node metastases rate of locoregional and non-locoregional lymph node stations in gastric cancer
por: de Jong, Mees Hendrik Siert, et al.
Publicado: (2022)

Proton Reirradiation for Locoregionally Recurrent Breast Cancer
por: LaRiviere, Michael J., et al.
Publicado: (2021)

Salvage locoregional therapies for recurrent hepatocellular carcinoma
por: Criss, Cody R, et al.
Publicado: (2023)

CT-guided palladium-103 seed brachytherapy for metastatic adenoid cystic carcinoma: a retrospective study to assess initial safety and effectiveness of percutaneous CT fluoroscopy-guided permanent seed brachytherapy
por: Doggett, Stephen W., et al.
Publicado: (2021)

Association of TIMP-2-418G/C and TIMP-2-303G/A with gastric cancer: a meta-analysis
por: Yang, Yan, et al.
Publicado: (2016)

Prior Local or Systemic Treatment: A Predictive Model Could Guide Clinical Decision-Making for Locoregional Recurrent Breast Cancer
por: Wu, Huai-liang, et al.
Publicado: (2022)

CT-guided (125)I brachytherapy for locally recurrent nasopharyngeal carcinoma
por: Yan, Huzheng, et al.
Publicado: (2017)

Carotid dosimetry after re-irradiation with (131)Cs permanent implant brachytherapy in recurrent, resected head and neck cancer
por: Walsh, Amanda, et al.
Publicado: (2019)

LOCL-15 PERMANENT CARRIER-EMBEDDED CESIUM-131 BRACHYTHERAPY FOR THE SALVAGE TREATMENT OF PREVIOUSLY IRRADIATED, RECURRENT BRAIN METASTASES
por: Imber, Brandon S, et al.
Publicado: (2022)

Higher Numbers of T-Bet(+) Tumor-Infiltrating Lymphocytes Associate with Better Survival in Human Epithelial Ovarian Cancer
por: Xu, Yun, et al.
Publicado: (2017)

Effect of constipation on dosimetry after permanent seed brachytherapy for prostate cancer
por: Otón, L. Fernando, et al.
Publicado: (2015)

A comparative evaluation of loading times and exposures for permanent prostate brachytherapy
por: Bice, W. S., et al.
Publicado: (2002)

Locoregional therapies in patients with recurrent intrahepatic cholangiocarcinoma after curative resection
por: Liu, Hsiao-Tien, et al.
Publicado: (2020)

Decreased RIG-I expression is associated with poor prognosis and promotes cell invasion in human gastric cancer
por: Chen, Lujun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k038m1dt6145jhsdcn0nnd6v8i